BINEX stock | 2026 trend & analyst price target

BINEX

KOSDAQ:A053030

₩ 11.530,00

+ ₩30,00 (0,26%)

11.530,00 ₩

+₩30,00 (0,26%)

End-of-day quote: 04/23/2026

BINEX Stock Value

Analysts currently give BINEX a rating of Outperform.

Outperform

BINEX Company Info

EPS Growth 5Y

-14,91%

Market Cap

₩366,25 B

Long-Term Debt

₩43,56 B

Annual earnings

N/A

Dividend

₩0,00

Dividend Yield

0,00%

Founded

1957

Industry

Health Care

Country

South Korea

Website

BINEX

ISIN Number

KR7053030003

Website

http://www.bi-nex.co.kr

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

₩17.400,00

50.91%

Last Update: 04/23/2026

Analysts: 1

Highest Price Target ₩17.400,00

Average Price Target ₩17.400,00

Lowest Price Target ₩17.400,00

In the last five quarters, BINEX’s Price Target has fallen from ₩61.758,20 to ₩30.700,00 - a -50,29% decrease. One analysts predict that BINEX’s share price will increase in the coming year, reaching ₩17.400,00. This would represent an increase of 50,91%.

Top growth stocks in the health care sector (5Y.)

What does BINEX do?

BINEX Co., Ltd. operates as a pharmaceutical company. Business Segments The company operates through two primary segments: Pharmaceutical and Biopharmaceutical. Pharmaceutical segment This segment focuses on the manufacturing and sale of synthetic drugs. The company produces a range of pharmaceutical products, which are distributed to major wholesalers and distributors. Biopharmaceutical segment This segment engages in the development and manufacturing of biopharmaceutical products. The co...

BINEX Co., Ltd. operates as a pharmaceutical company.

Business Segments

The company operates through two primary segments: Pharmaceutical and Biopharmaceutical.

Pharmaceutical segment

This segment focuses on the manufacturing and sale of synthetic drugs. The company produces a range of pharmaceutical products, which are distributed to major wholesalers and distributors.

Biopharmaceutical segment

This segment engages in the development and manufacturing of biopharmaceutical products. The company services encompass process development, scale-up, clinical manufacturing, and commercial production. The company’s clients in this segment include biopharmaceutical companies such as Boehringer Ingelheim and Compass Therapeutics.

The company’s biopharmaceutical segment also includes bioanalysis services, which provide analytical testing and validation services necessary for regulatory submissions and quality assurance.

Business Strategy

The company’s business strategy is centered on leveraging its expertise in pharmaceutical and biopharmaceutical manufacturing and development to deliver high-quality products and services to its clients.

The company’s strategy involves continuous investment in research and development to drive innovation and maintain a competitive edge in the market. The company’s R&D efforts focuses on developing new technologies, improving existing processes, and expanding its capabilities in biopharmaceutical development and manufacturing.

The company’s strategy includes building and maintaining strong relationships with key clients in the pharmaceutical and biopharmaceutical industries. The company’s customer-centric approach is reflected in its commitment to understanding and meeting the needs of its clients, providing customized solutions, and delivering value-added services.

The company’s strategy also involves expanding its service offerings to include a broader range of analytical and bioanalysis services, supporting clients throughout the product lifecycle. The company’s integrated approach to pharmaceutical and biopharmaceutical development and manufacturing enables it to provide clients with a one-stop solution for their development and production needs.

Products and Services

The company offers a comprehensive range of products and services across its pharmaceutical and biopharmaceutical business segments. In the pharmaceutical segment, the company manufactures and sells synthetic drugs, which are distributed to major wholesalers and distributors.

In the biopharmaceutical segment, the company provides contract development and manufacturing organization (CDMO) services, supporting clients in the development and manufacturing of biopharmaceutical products. The company’s CDMO services include process development, scale-up, clinical manufacturing, and commercial production.

The company’s bioanalysis services complement its CDMO offerings by providing analytical testing and validation services necessary for regulatory submissions and quality assurance. The company’s integrated service offerings provide clients with a one-stop solution for their pharmaceutical and biopharmaceutical development and production needs.

Geographical Markets

The company serves both domestic and international markets through its pharmaceutical and biopharmaceutical business segments.

Customers

The company’s customer base includes major domestic pharmaceutical wholesalers and distributors, as well as biopharmaceutical companies, including Boehringer Ingelheim and Compass Therapeutics. The company serves a diverse range of customers in the pharmaceutical and biopharmaceutical sectors. The company’s customer base includes both domestic and international clients in the healthcare industry.

Sales and Marketing

The company’s sales and marketing activities are conducted through direct relationships with major pharmaceutical wholesalers and distributors for its pharmaceutical products. The company’s biopharmaceutical CDMO services are marketed to domestic and international biopharmaceutical companies seeking development and manufacturing support.

Government Regulations

The company’s operations are conducted in compliance with Korean International Financial Reporting Standards (K-IFRS) and other relevant accounting and regulatory standards. The company’s manufacturing and development activities are subject to Good Manufacturing Practice (GMP) standards.

History

BINEX Co., Ltd. was founded in 1957.

New support ticket

Explore

BINEX Stock Value

BINEX Company Info

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does BINEX do?

Offer & Services

Service & Collaboration

Company & Legal

New support ticket

Explore

BINEX Stock Value

BINEX Company Info

Analyst Price Target The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

Top growth stocks in the health care sector (5Y.)

What does BINEX do?

Offer & Services

Service & Collaboration

Company & Legal

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.